Tell Me Your Story and I'll Send You This Book

We just celebrated the year-and-a-half anniversary of the launch of Private Briefing, and we've got a lot to be happy about. We've recommended as many as 66 winners - including two triples, three doubles and five takeovers.

Some of our biggest winners - and their peak gains - include:

  • Pharmacyclics Inc. (Nasdaq: PCYC), up 222%
  • Galapagos NV (PINK ADR: GLPYY), 205%.
  • NQ Mobile (NYSE ADR: NQ), 153%.
  • Sandstorm Inc. (TSE: SSL), 142%.
  • Celldex Therapeutics Inc. (Nasdaq: CLDX), 105%
  • Valero Inc. (NYSE: VLO), 95%
  • HollyFrontier Corp. (NYSE: HFC), 86%.
  • American Railcar Industries Inc. (Nasdaq: ARII), 77%.
  • Accuray Inc. (Nasdaq: ARAY), 72%
  • Pentair Inc. (NYSE: PNR), 67%.
  • CNH Global NV (NYSE ADR: CNH), 67%.
  • Nexen Inc. (NYSE: NXY), 63% and 41% (we recommended it twice);
  • CrossTex Energy Partners (NYSE: XTXI), 53%.
  • Molycorp Inc. (NYSE: MCP), 50%
  • ProShares UltraShort Yen (NYSE: YCS): 45%.
  • Delcath Systems Inc. (Nasdaq: DCTH), 42%.
  • Oiltanking Partners LP (NYSE: OILT), 41%.
  • NXP Semiconductors Inc. (NYSE ADR: NXTI): 41%
  • U.S. Gasoline Fund (NYSE: UGA), 39%.
  • eBay Inc. (Nasdaq: EBAY), 39%.
And we've done more than provide stock tips. Our experts have provided answers to your toughest questions, and we've detailed cutting-edge investment strategies for you. We've provided special research reports with winning picks in biotechnology, mining and digital technology. And we've provided insights about world events - the South China Sea affair and the Cyber-Hacking of America are just two of many - long before those stories hit the mainstream press.

To continue reading, please click here…

  1. 000059318524 | March 5, 2013

    My story is I haven't been investing for quite some time.I would like to start again,but need a few pointers.Thanks.p.s.I like private breifing.

  2. 000059285838 | March 5, 2013

    Hi, I just joined Private Briefing today. What are the stock recommendations you have for late comer?

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK